期刊文献+

沙培林联合顺铂治疗恶性胸水临床疗效观察 被引量:7

The clinical effect of streptococcus combined cisplatin on patients with cancer accompanied severe hydrothorax
下载PDF
导出
摘要 目的探讨沙培林联合顺铂活疗恶性胸水的临床疗效。方法将收治的74例患者随机分为三组:治疗组采用沙培林加顺铂治疗,对照组分别单用顺铂治疗或单用沙培林治疗。结果沙培林联用顺铂治疗恶性胸水的疗效优于单用顺铂或单用沙培林,而且减少了单用顺铂的副作用。结论沙培林联合顺铂治提高了癌性胸腔积液的治疗效果,改善了患者的生存质量。 Objective: To investigate the effective therapy of cancer accompanied with severe hydrothorax. Methods : 74 patiens with severe hydrothorax of cancer cure in our department were observed. The clinical effects of streptococcus and cisplatin on these patients were evaluated. They were divided into three groups firstly, then these groups were treated with cisplatin, streptococcus, and cisplatin combined streptococcus respectively. Results: The resuls showed that the treatment with cisplatin combined streptococcus not only increased the clinical cure effects of patients with cancer accompanied severe hydrothorax but also relieved the side effects of eisplatin significantly. Conclusion: Streptococcus combined cisplatin iin-creases the therapeautie effect on cancer accompanied with severe hydrothoraxand and improves living quality of the patients.
出处 《泰山医学院学报》 CAS 2007年第6期418-419,共2页 Journal of Taishan Medical College
关键词 沙培林 顺铂 胸水 streptococcus cisplatin hydrothorax
  • 相关文献

参考文献7

二级参考文献11

  • 1赵家美,廖美琳,金长娟,李小青.生物反应调节剂在恶性胸腔积液中的应用[J].上海医学,1993,16(9):539-541. 被引量:32
  • 2张心敏,瘳美琳,王家明.白细胞介素2在胸部肿瘤中的应用探讨[J].实用肿瘤杂志,1995,10(3):19-19. 被引量:2
  • 3张天泽 徐光炜.肿瘤学[M].天津:天津技术出版社,1998.1402.
  • 4赵家美 廖美琳 等.沙培林对癌性胸腔积液的治疗观察[J].中华结核和呼吸杂志,1994,17:161-161.
  • 5张伟亮 陈克平.胸腔闭式引流及注入滑石粉混悬液治疗恶性胸水[J].癌症,1997,16:49-49.
  • 6廖美琳,肺癌现代治疗,1998年,327页
  • 7张心敏,实用肿瘤杂志,1995年,10卷,3期,194页
  • 8赵家美,中华结核和呼吸杂志,1994年,17卷,6期,161页
  • 9赵家美,上海医学,1993年,16卷,9期,161页
  • 10Lee RE,Lotze MT,Skibber JM,et al.Cardiorespiratory effects of immunotherapy with interleukin-2[].Journal of Clinical Oncology.1989

共引文献58

同被引文献45

  • 1张玉库,马建忠,王洪建.化疗联合胸腔内注射沙培林治疗肺癌伴大量胸腔积液40例临床观察[J].现代肿瘤医学,2006,14(2):169-170. 被引量:5
  • 2陆筱灵,左云,刘卓.胸腔闭塞引流后灌注顺铂及天地欣治疗恶性胸腔积液临床观察[J].中国肿瘤临床与康复,2006,13(4):362-363. 被引量:12
  • 3隋建超.顺铂与氟尿嘧啶腔内注射治疗恶性胸腹腔积液58例分析[J].新医学,1999,30(1):25-25.
  • 4胡赤厂 呈永方.胸腔内灌注化疗治疗晚期恶性胸腔秘液[J].肿瘤防治研究,1997,24(6):367-368.
  • 5Okam M. Immunological analysis and clinical effects of intra abdominal and sintrap leural in iection of Lentinan for malignant ascites and pleural effusion. Biotherapy, 1992, 5 : 107.
  • 6Ostriowali ML. assessment of the longterm results of controlling reacumulation of malignant effusions using intracavity bleomyein. Cancer, 1986,56 : 721-723.
  • 7Muraoka M, Oka T, Akamine S, et al. Modified intrapleural eisplatintreatmenl for lung cancer with positive pleural lavage cytology or malignant effusion. J Surg Oncol, 2006, 93 (4): 255-256.
  • 8Ren S, Teman DS, Bohach G, et al. Intrapleural staphylococcal superantingen indices resolution of malignant pleural effusion and a survival benefit in nonsmall cell lung cancer[ J ]. Chest,2004, 126(5) :1529.
  • 9Antony VB,Loddenkemper R,Astoul P,et al. Management of malignant pleural effnsions[ J]. Eur Respir J,2001,18(2) :402.
  • 10Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions [ J ]. Chest, 2000,117 ( 1 ) :79.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部